AU2002350660A1 - Non-neurotoxic plasminogen activating factors for treating stroke - Google Patents

Non-neurotoxic plasminogen activating factors for treating stroke

Info

Publication number
AU2002350660A1
AU2002350660A1 AU2002350660A AU2002350660A AU2002350660A1 AU 2002350660 A1 AU2002350660 A1 AU 2002350660A1 AU 2002350660 A AU2002350660 A AU 2002350660A AU 2002350660 A AU2002350660 A AU 2002350660A AU 2002350660 A1 AU2002350660 A1 AU 2002350660A1
Authority
AU
Australia
Prior art keywords
treating stroke
activating factors
plasminogen activating
neurotoxic plasminogen
neurotoxic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002350660A
Other versions
AU2002350660B2 (en
AU2002350660C1 (en
Inventor
Robert Medcalf
Wolf-Dieter Schleuning
Mariola Sohngen
Wolfgang Sohngen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10153601A external-priority patent/DE10153601A1/en
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of AU2002350660A1 publication Critical patent/AU2002350660A1/en
Publication of AU2002350660B2 publication Critical patent/AU2002350660B2/en
Priority to AU2008201735A priority Critical patent/AU2008201735A1/en
Assigned to PAION DEUTSCHLAND GMBH reassignment PAION DEUTSCHLAND GMBH Alteration of Name(s) of Applicant(s) under S113 Assignors: PAION GMBH
Application granted granted Critical
Publication of AU2002350660C1 publication Critical patent/AU2002350660C1/en
Assigned to H. LUNDBECK A/S reassignment H. LUNDBECK A/S Request for Assignment Assignors: PAION DEUTSCHLAND GMBH
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002350660A 2001-11-02 2002-10-31 Non-neurotoxic plasminogen activating factors for treating stroke Ceased AU2002350660C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2008201735A AU2008201735A1 (en) 2001-11-02 2008-04-16 Non-neurotoxic plasminogen activating factors for treating stroke

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10153601A DE10153601A1 (en) 2001-11-02 2001-11-02 DSPA for the treatment of stroke
DE10153601.1 2001-11-02
EP01130006A EP1308166B1 (en) 2001-11-02 2001-12-17 Non-neurotoxic plasminogen activating factors for treating stroke
EP01130006.8 2001-12-17
PCT/EP2002/012204 WO2003037363A2 (en) 2001-11-02 2002-10-31 Non-neurotoxic plasminogen activating factors for treating stroke

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2008201735A Division AU2008201735A1 (en) 2001-11-02 2008-04-16 Non-neurotoxic plasminogen activating factors for treating stroke

Publications (3)

Publication Number Publication Date
AU2002350660A1 true AU2002350660A1 (en) 2003-07-10
AU2002350660B2 AU2002350660B2 (en) 2008-04-10
AU2002350660C1 AU2002350660C1 (en) 2008-10-09

Family

ID=7704253

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002350660A Ceased AU2002350660C1 (en) 2001-11-02 2002-10-31 Non-neurotoxic plasminogen activating factors for treating stroke

Country Status (27)

Country Link
US (7) US20050048027A1 (en)
EP (4) EP1308166B1 (en)
JP (2) JP5004407B2 (en)
KR (3) KR100816221B1 (en)
CN (2) CN101156948A (en)
AT (3) ATE440614T1 (en)
AU (1) AU2002350660C1 (en)
BR (1) BR0213856A (en)
CA (1) CA2465792C (en)
CY (3) CY1108446T1 (en)
DE (3) DE10153601A1 (en)
DK (3) DK1308166T3 (en)
EA (3) EA010858B1 (en)
ES (3) ES2332576T3 (en)
HK (1) HK1057328A1 (en)
HR (1) HRP20040383B1 (en)
HU (1) HU230163B1 (en)
IL (1) IL205695A0 (en)
MX (1) MXPA04004155A (en)
NO (1) NO329789B1 (en)
NZ (2) NZ532903A (en)
PL (1) PL208343B1 (en)
PT (3) PT1308166E (en)
SG (1) SG148034A1 (en)
SI (2) SI1997510T1 (en)
WO (1) WO2003037363A2 (en)
ZA (1) ZA200403285B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153601A1 (en) 2001-11-02 2003-05-22 Paion Gmbh DSPA for the treatment of stroke
PL1622639T3 (en) * 2003-05-02 2013-06-28 Lundbeck H As Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
WO2004096267A1 (en) * 2003-05-02 2004-11-11 Paion Gmbh Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke
US20060135425A1 (en) * 2003-05-02 2006-06-22 Paion Deutschland Gmbh Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
US20080057050A1 (en) * 2003-05-02 2008-03-06 Paion Deutschland Gmbh Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
CA2524342A1 (en) * 2003-05-05 2004-11-18 Paion Deutschland Gmbh Glutamate receptor antagonists as neuroprotectives
DE10342518A1 (en) * 2003-09-12 2005-05-12 Paion Gmbh Plasminogen activators with reduced lysine binding capacity
JP2006241109A (en) * 2005-03-04 2006-09-14 Paion Deutschland Gmbh FUSION PROTEIN CONTAINING ANTIBODY AGAINST HUMAN P SELECTIN AND DSPAalpha1
AR068914A1 (en) * 2007-10-18 2009-12-16 Paion Deutschland Gmbh USE OF A PLASMINOGEN ACTIVATOR FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF APOPLEJIA
WO2011107299A2 (en) 2010-04-16 2011-09-09 Paion Deutschland Gmbh Method for the manufacture of recombinant dspa alpha1
MX337248B (en) * 2011-01-05 2016-02-19 Thrombogenics Nv Plasminogen and plasmin variants.
US9644196B2 (en) 2011-08-12 2017-05-09 Thrombogenics Nv Plasminogen and plasmin variants
US11613744B2 (en) 2018-12-28 2023-03-28 Vertex Pharmaceuticals Incorporated Modified urokinase-type plasminogen activator polypeptides and methods of use
PE20211664A1 (en) * 2018-12-28 2021-08-26 Catalyst Biosciences Inc MODIFIED PLASMINOGEN ACTIVATOR POLYPEPTIDES, UROKINASE TYPE, AND METHODS OF USE

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68561A (en) 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
US4766075A (en) 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
US5244806A (en) * 1985-08-26 1993-09-14 Eli Lilly And Company DNA encoding novel tissue plasminogen activator derivatives having kringles 1 and 2 deleted, vectors and host cells
DE3643158A1 (en) 1986-04-21 1987-11-19 Boehringer Mannheim Gmbh TISSUE PLASMINOGEN ACTIVATOR (TPA) DERIVATIVE AND ITS PRODUCTION
JPH087179B2 (en) * 1986-09-27 1996-01-29 日本碍子株式会社 Gas sensor
WO1988005081A2 (en) * 1986-12-30 1988-07-14 Cetus Corporation Novel plasminogen activator
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of tissue plasminogen activator comprising only the kringle 2 and protease domain dna encoding the same processes for the preparation thereof and pharmaceutical compositions containing the same
EP0386240B1 (en) * 1987-10-29 1995-07-19 Yamanouchi Pharmaceutical Co. Ltd. Novel polypeptide compounds
US5094953A (en) * 1988-03-21 1992-03-10 Genentech, Inc. Human tissue plasminogen activator variants
IE69054B1 (en) * 1988-07-20 1996-08-07 Schering Ag Vampire bat salivary plasminogen activators
DE3825253A1 (en) 1988-07-25 1990-02-01 Boehringer Mannheim Gmbh T-PA DERIVATIVE AND ITS PRODUCTION
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
JPH0273774A (en) * 1988-09-09 1990-03-13 Nec Corp Facsimile equipment
GB8901422D0 (en) * 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co New tissue plasminogen activator
US5676947A (en) * 1989-02-07 1997-10-14 Boehringer Manneheim Gmbh Method for treating thromboembolic conditions using thrombolytically active proteins
DE3903581A1 (en) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh FABRIC PLASMINOGEN ACTIVATOR DERIVATIVE
DE3917949A1 (en) * 1989-05-30 1991-01-24 Schering Ag New fibrin specific thrombolytic agent v-PA
US6008019A (en) 1989-02-13 1999-12-28 Schering Aktiengesellschaft Plasminogen activator from saliva of the vampire bat
WO1990009438A1 (en) * 1989-02-13 1990-08-23 Schering Aktiengesellschaft Berlin Und Bergkamen Novel thrombolytic
DE3904580A1 (en) 1989-02-13 1990-08-16 Schering Ag Thrombolytic agent
US5891664A (en) * 1989-04-07 1999-04-06 Cancerforskningsfondet Af 1989 Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR)
CA2051676A1 (en) * 1989-04-07 1990-10-08 Keld Dano Urokinase-type plasminogen activator receptor
JPH0352119A (en) * 1989-07-19 1991-03-06 Matsushita Electric Ind Co Ltd Optical recording and reproducing device
NL8902454A (en) 1989-10-03 1991-05-01 Stichting Centraal Lab MUTANTS OF THE HUMANE PLASMINOGENIC ACTIVATOR INHIBITOR 1 (PAI-1), THEIR PREPARATION AND USE, AND RECOMBINANT POLYNUCLEOTIDES INCLUDING GENETIC INFORMATION CODING FOR THESE MUTANTS.
US5326700A (en) * 1990-11-06 1994-07-05 Eli Lilly And Company DNA sequences encoding t-PA derivatives with cleavable sites
DE4123845A1 (en) * 1991-07-18 1993-01-21 Boehringer Mannheim Gmbh Compsn. for treating thromboembolic disease with plasminogen activator
DE59204945D1 (en) * 1991-04-16 1996-02-15 Boehringer Mannheim Gmbh PHARMACEUTICAL PACKAGING UNIT CONTAINING PLASMINOGEN ACTIVATORS FOR MULTIPLE BOLUS ADMINISTRATION
US5595736A (en) * 1991-04-22 1997-01-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders
NL9101520A (en) * 1991-09-09 1993-04-01 Stork Fibron Bv METHOD FOR MANUFACTURING AN EDIBLE PRODUCT
ATE145669T1 (en) 1991-12-16 1996-12-15 Genentech Inc T-PA SUBSTITUTION VARIANTS WITH IMPROVED FIBRIN SPECIFICITY
EP0677107B1 (en) * 1992-12-04 1997-08-06 Schering Aktiengesellschaft Clotting inhibitor made from protostomia saliva
US5510330A (en) * 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
GB9412131D0 (en) * 1994-06-17 1994-08-10 British Bio Technology Thrombolytic composition
DE4423574A1 (en) 1994-07-05 1996-01-11 Boehringer Mannheim Gmbh Non-glycosylated plasminogen activator derivatives and their use when there is an increased risk of bleeding
US5827832A (en) * 1995-03-06 1998-10-27 Interneuron Pharmaceuticals, Inc. Method of protecting brain tissue from cerebral infarction subsequent to ischemia
US5786187A (en) * 1995-09-21 1998-07-28 The Research Foundation Of State University Of New York Method for reducing neuronal degeneration associated with seizure
US5945432A (en) * 1995-12-22 1999-08-31 The University Of Vermont And State Agricultural College Thrombolytic agents and thienopyridine derivatives in acute stroke
US20020081294A1 (en) * 1996-01-23 2002-06-27 Genentech, Inc. Co-administration of a thrombolytic and an anti-CD18 antibody in stroke
US5731186A (en) * 1996-02-05 1998-03-24 Schering Aktiengesellschaft Method for the production of rDSPA α1
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation
US5830349A (en) * 1996-07-22 1998-11-03 Dana Corporation Flow inverter for filters
US6235278B1 (en) 1996-10-01 2001-05-22 University Of Georgia Research Foundation, Inc. Biological insect control agents expressing insect-specific toxin genes, methods and compositions
US6008109A (en) * 1997-12-19 1999-12-28 Advanced Micro Devices, Inc. Trench isolation structure having a low K dielectric encapsulated by oxide
KR20010069066A (en) * 2000-01-12 2001-07-23 이종원 Culturing Method Which Allows Growth of Animal Cells Under Hypoxic Condition
DE10008646A1 (en) 2000-02-24 2001-09-13 Kempten Elektroschmelz Gmbh Molded body used as a cooking plate comprises an adhesion- and scratch-resistant surface coating made of glass and/or glass-ceramic formed on hot-pressed, gas pressure-sintered , reaction-bound or hot isostatically pressed silicon nitride
GB0025473D0 (en) * 2000-10-17 2000-11-29 Pfizer Ltd Pharmaceutical combinations
US20020089179A1 (en) * 2000-12-30 2002-07-11 Levon Guyumjan Hose coupling apparatus and method
DE10153601A1 (en) 2001-11-02 2003-05-22 Paion Gmbh DSPA for the treatment of stroke
PL1622639T3 (en) 2003-05-02 2013-06-28 Lundbeck H As Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
US20060135425A1 (en) 2003-05-02 2006-06-22 Paion Deutschland Gmbh Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
US20080057050A1 (en) 2003-05-02 2008-03-06 Paion Deutschland Gmbh Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
WO2004096267A1 (en) 2003-05-02 2004-11-11 Paion Gmbh Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke
CA2524342A1 (en) 2003-05-05 2004-11-18 Paion Deutschland Gmbh Glutamate receptor antagonists as neuroprotectives
US20050085478A1 (en) 2003-08-22 2005-04-21 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a low-molecular-weight heparin for the treatment of central nervous system damage
DE10342518A1 (en) 2003-09-12 2005-05-12 Paion Gmbh Plasminogen activators with reduced lysine binding capacity
AR068914A1 (en) 2007-10-18 2009-12-16 Paion Deutschland Gmbh USE OF A PLASMINOGEN ACTIVATOR FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF APOPLEJIA

Similar Documents

Publication Publication Date Title
AU2002324574A1 (en) Methods for treating prostatitis
EP1454085A4 (en) Process control valve
EP1286411A3 (en) Satellite-tracking antenna controlling apparatus
AU2002342613A1 (en) Treatment for wounds
AU2002333819A1 (en) Methods for controlling screenouts
AU2002350660A1 (en) Non-neurotoxic plasminogen activating factors for treating stroke
AU2002225930A1 (en) Methods for treating phosphatide-containing mixtures
HUP0402165A3 (en) Non-neurotoxic plasminogen activating factors for treating stroke
AU2002343408A1 (en) Method for wrapped-gate mosfet
AU2002308642A1 (en) Methods for treating cancer
AU2002352002A1 (en) Anti-aging agents
AU2002323774A1 (en) New compounds for treating impotence
AU2002335667A1 (en) Modified reoviral therapy
AUPR349501A0 (en) Cellular production control
AU2002326991A1 (en) Methods for treating multiple sclerosis
AU2002365372A1 (en) New process
AU2002337328A1 (en) Process for controlling valence states
AU2001258675A1 (en) Treating infections
AU2002241600A1 (en) Nitrile process
AU2002366617A1 (en) Device for treating headache
AU2002353675A1 (en) Process control valve
AU2002348972A1 (en) Polarization controlling
AU2002302773A1 (en) Improved process control
AU2002343298A1 (en) Hardening process
AU2002257482A1 (en) Capacitance controlling process